The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Antiasthmatic Drug Market Research Report 2024
Synopsis
Antiasthmatic drugs refer to the drugs that can eliminate chronic airway inflammation, relieve bronchoconstriction and spasm, dilate bronchus and reduce airway hyperresponsiveness.
The global Antiasthmatic Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Antiasthmatic Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antiasthmatic Drug.
Report Scope
The Antiasthmatic Drug market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Antiasthmatic Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antiasthmatic Drug companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novartis AG
GlaxoSmithKline
ABC Farmaceutici Spa
AstraZeneca
Teva Pharmaceutical Industries Ltd
Mundipharma Pharmaceuticals Ltd.
MSD
Daiichi Sankyo Company Limited
Chiesi GmbH
Kyorin Pharmaceutical Co.,Ltd.
Kissei Pharmaceutical Co.Ltd.
Ruiyang Pharmaceutical Co., Ltd
Chiesi Pharmaceutical (Shangai) Co., Ltd
Fuhe Group
Lunan Pharmaceutical Group Co., Ltd
Chengdu Huayu Pharmaceutical Co., Ltd
Kaifeng Kangnuo Pharmaceutical Co., Ltd
Akorn Pharmaceutical Co.Ltd.
Boehringer Ingelheim Pharma GmbH&Co.KG
Covis Pharmaceutical Inc
Roche
Segment by Type
Bronchodilators
Anti-allergic Antiasthmatic
Anti-inflammatory Antiasthmatic
Segment by Application
Need for Acute Attack of Asthma
Treatment of Chronic Asthma
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Antiasthmatic Drug companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Antiasthmatic drugs refer to the drugs that can eliminate chronic airway inflammation, relieve bronchoconstriction and spasm, dilate bronchus and reduce airway hyperresponsiveness.
The global Antiasthmatic Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Antiasthmatic Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antiasthmatic Drug.
Report Scope
The Antiasthmatic Drug market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Antiasthmatic Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antiasthmatic Drug companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novartis AG
GlaxoSmithKline
ABC Farmaceutici Spa
AstraZeneca
Teva Pharmaceutical Industries Ltd
Mundipharma Pharmaceuticals Ltd.
MSD
Daiichi Sankyo Company Limited
Chiesi GmbH
Kyorin Pharmaceutical Co.,Ltd.
Kissei Pharmaceutical Co.Ltd.
Ruiyang Pharmaceutical Co., Ltd
Chiesi Pharmaceutical (Shangai) Co., Ltd
Fuhe Group
Lunan Pharmaceutical Group Co., Ltd
Chengdu Huayu Pharmaceutical Co., Ltd
Kaifeng Kangnuo Pharmaceutical Co., Ltd
Akorn Pharmaceutical Co.Ltd.
Boehringer Ingelheim Pharma GmbH&Co.KG
Covis Pharmaceutical Inc
Roche
Segment by Type
Bronchodilators
Anti-allergic Antiasthmatic
Anti-inflammatory Antiasthmatic
Segment by Application
Need for Acute Attack of Asthma
Treatment of Chronic Asthma
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Antiasthmatic Drug companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antiasthmatic Drug Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Bronchodilators
1.2.3 Anti-allergic Antiasthmatic
1.2.4 Anti-inflammatory Antiasthmatic
1.3 Market by Application
1.3.1 Global Antiasthmatic Drug Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Need for Acute Attack of Asthma
1.3.3 Treatment of Chronic Asthma
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Antiasthmatic Drug Market Perspective (2019-2030)
2.2 Antiasthmatic Drug Growth Trends by Region
2.2.1 Global Antiasthmatic Drug Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Antiasthmatic Drug Historic Market Size by Region (2019-2024)
2.2.3 Antiasthmatic Drug Forecasted Market Size by Region (2025-2030)
2.3 Antiasthmatic Drug Market Dynamics
2.3.1 Antiasthmatic Drug Industry Trends
2.3.2 Antiasthmatic Drug Market Drivers
2.3.3 Antiasthmatic Drug Market Challenges
2.3.4 Antiasthmatic Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Antiasthmatic Drug Players by Revenue
3.1.1 Global Top Antiasthmatic Drug Players by Revenue (2019-2024)
3.1.2 Global Antiasthmatic Drug Revenue Market Share by Players (2019-2024)
3.2 Global Antiasthmatic Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Antiasthmatic Drug Revenue
3.4 Global Antiasthmatic Drug Market Concentration Ratio
3.4.1 Global Antiasthmatic Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antiasthmatic Drug Revenue in 2023
3.5 Antiasthmatic Drug Key Players Head office and Area Served
3.6 Key Players Antiasthmatic Drug Product Solution and Service
3.7 Date of Enter into Antiasthmatic Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Antiasthmatic Drug Breakdown Data by Type
4.1 Global Antiasthmatic Drug Historic Market Size by Type (2019-2024)
4.2 Global Antiasthmatic Drug Forecasted Market Size by Type (2025-2030)
5 Antiasthmatic Drug Breakdown Data by Application
5.1 Global Antiasthmatic Drug Historic Market Size by Application (2019-2024)
5.2 Global Antiasthmatic Drug Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Antiasthmatic Drug Market Size (2019-2030)
6.2 North America Antiasthmatic Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Antiasthmatic Drug Market Size by Country (2019-2024)
6.4 North America Antiasthmatic Drug Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Antiasthmatic Drug Market Size (2019-2030)
7.2 Europe Antiasthmatic Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Antiasthmatic Drug Market Size by Country (2019-2024)
7.4 Europe Antiasthmatic Drug Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Antiasthmatic Drug Market Size (2019-2030)
8.2 Asia-Pacific Antiasthmatic Drug Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Antiasthmatic Drug Market Size by Region (2019-2024)
8.4 Asia-Pacific Antiasthmatic Drug Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Antiasthmatic Drug Market Size (2019-2030)
9.2 Latin America Antiasthmatic Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Antiasthmatic Drug Market Size by Country (2019-2024)
9.4 Latin America Antiasthmatic Drug Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Antiasthmatic Drug Market Size (2019-2030)
10.2 Middle East & Africa Antiasthmatic Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Antiasthmatic Drug Market Size by Country (2019-2024)
10.4 Middle East & Africa Antiasthmatic Drug Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis AG
11.1.1 Novartis AG Company Detail
11.1.2 Novartis AG Business Overview
11.1.3 Novartis AG Antiasthmatic Drug Introduction
11.1.4 Novartis AG Revenue in Antiasthmatic Drug Business (2019-2024)
11.1.5 Novartis AG Recent Development
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Company Detail
11.2.2 GlaxoSmithKline Business Overview
11.2.3 GlaxoSmithKline Antiasthmatic Drug Introduction
11.2.4 GlaxoSmithKline Revenue in Antiasthmatic Drug Business (2019-2024)
11.2.5 GlaxoSmithKline Recent Development
11.3 ABC Farmaceutici Spa
11.3.1 ABC Farmaceutici Spa Company Detail
11.3.2 ABC Farmaceutici Spa Business Overview
11.3.3 ABC Farmaceutici Spa Antiasthmatic Drug Introduction
11.3.4 ABC Farmaceutici Spa Revenue in Antiasthmatic Drug Business (2019-2024)
11.3.5 ABC Farmaceutici Spa Recent Development
11.4 AstraZeneca
11.4.1 AstraZeneca Company Detail
11.4.2 AstraZeneca Business Overview
11.4.3 AstraZeneca Antiasthmatic Drug Introduction
11.4.4 AstraZeneca Revenue in Antiasthmatic Drug Business (2019-2024)
11.4.5 AstraZeneca Recent Development
11.5 Teva Pharmaceutical Industries Ltd
11.5.1 Teva Pharmaceutical Industries Ltd Company Detail
11.5.2 Teva Pharmaceutical Industries Ltd Business Overview
11.5.3 Teva Pharmaceutical Industries Ltd Antiasthmatic Drug Introduction
11.5.4 Teva Pharmaceutical Industries Ltd Revenue in Antiasthmatic Drug Business (2019-2024)
11.5.5 Teva Pharmaceutical Industries Ltd Recent Development
11.6 Mundipharma Pharmaceuticals Ltd.
11.6.1 Mundipharma Pharmaceuticals Ltd. Company Detail
11.6.2 Mundipharma Pharmaceuticals Ltd. Business Overview
11.6.3 Mundipharma Pharmaceuticals Ltd. Antiasthmatic Drug Introduction
11.6.4 Mundipharma Pharmaceuticals Ltd. Revenue in Antiasthmatic Drug Business (2019-2024)
11.6.5 Mundipharma Pharmaceuticals Ltd. Recent Development
11.7 MSD
11.7.1 MSD Company Detail
11.7.2 MSD Business Overview
11.7.3 MSD Antiasthmatic Drug Introduction
11.7.4 MSD Revenue in Antiasthmatic Drug Business (2019-2024)
11.7.5 MSD Recent Development
11.8 Daiichi Sankyo Company Limited
11.8.1 Daiichi Sankyo Company Limited Company Detail
11.8.2 Daiichi Sankyo Company Limited Business Overview
11.8.3 Daiichi Sankyo Company Limited Antiasthmatic Drug Introduction
11.8.4 Daiichi Sankyo Company Limited Revenue in Antiasthmatic Drug Business (2019-2024)
11.8.5 Daiichi Sankyo Company Limited Recent Development
11.9 Chiesi GmbH
11.9.1 Chiesi GmbH Company Detail
11.9.2 Chiesi GmbH Business Overview
11.9.3 Chiesi GmbH Antiasthmatic Drug Introduction
11.9.4 Chiesi GmbH Revenue in Antiasthmatic Drug Business (2019-2024)
11.9.5 Chiesi GmbH Recent Development
11.10 Kyorin Pharmaceutical Co.,Ltd.
11.10.1 Kyorin Pharmaceutical Co.,Ltd. Company Detail
11.10.2 Kyorin Pharmaceutical Co.,Ltd. Business Overview
11.10.3 Kyorin Pharmaceutical Co.,Ltd. Antiasthmatic Drug Introduction
11.10.4 Kyorin Pharmaceutical Co.,Ltd. Revenue in Antiasthmatic Drug Business (2019-2024)
11.10.5 Kyorin Pharmaceutical Co.,Ltd. Recent Development
11.11 Kissei Pharmaceutical Co.Ltd.
11.11.1 Kissei Pharmaceutical Co.Ltd. Company Detail
11.11.2 Kissei Pharmaceutical Co.Ltd. Business Overview
11.11.3 Kissei Pharmaceutical Co.Ltd. Antiasthmatic Drug Introduction
11.11.4 Kissei Pharmaceutical Co.Ltd. Revenue in Antiasthmatic Drug Business (2019-2024)
11.11.5 Kissei Pharmaceutical Co.Ltd. Recent Development
11.12 Ruiyang Pharmaceutical Co., Ltd
11.12.1 Ruiyang Pharmaceutical Co., Ltd Company Detail
11.12.2 Ruiyang Pharmaceutical Co., Ltd Business Overview
11.12.3 Ruiyang Pharmaceutical Co., Ltd Antiasthmatic Drug Introduction
11.12.4 Ruiyang Pharmaceutical Co., Ltd Revenue in Antiasthmatic Drug Business (2019-2024)
11.12.5 Ruiyang Pharmaceutical Co., Ltd Recent Development
11.13 Chiesi Pharmaceutical (Shangai) Co., Ltd
11.13.1 Chiesi Pharmaceutical (Shangai) Co., Ltd Company Detail
11.13.2 Chiesi Pharmaceutical (Shangai) Co., Ltd Business Overview
11.13.3 Chiesi Pharmaceutical (Shangai) Co., Ltd Antiasthmatic Drug Introduction
11.13.4 Chiesi Pharmaceutical (Shangai) Co., Ltd Revenue in Antiasthmatic Drug Business (2019-2024)
11.13.5 Chiesi Pharmaceutical (Shangai) Co., Ltd Recent Development
11.14 Fuhe Group
11.14.1 Fuhe Group Company Detail
11.14.2 Fuhe Group Business Overview
11.14.3 Fuhe Group Antiasthmatic Drug Introduction
11.14.4 Fuhe Group Revenue in Antiasthmatic Drug Business (2019-2024)
11.14.5 Fuhe Group Recent Development
11.15 Lunan Pharmaceutical Group Co., Ltd
11.15.1 Lunan Pharmaceutical Group Co., Ltd Company Detail
11.15.2 Lunan Pharmaceutical Group Co., Ltd Business Overview
11.15.3 Lunan Pharmaceutical Group Co., Ltd Antiasthmatic Drug Introduction
11.15.4 Lunan Pharmaceutical Group Co., Ltd Revenue in Antiasthmatic Drug Business (2019-2024)
11.15.5 Lunan Pharmaceutical Group Co., Ltd Recent Development
11.16 Chengdu Huayu Pharmaceutical Co., Ltd
11.16.1 Chengdu Huayu Pharmaceutical Co., Ltd Company Detail
11.16.2 Chengdu Huayu Pharmaceutical Co., Ltd Business Overview
11.16.3 Chengdu Huayu Pharmaceutical Co., Ltd Antiasthmatic Drug Introduction
11.16.4 Chengdu Huayu Pharmaceutical Co., Ltd Revenue in Antiasthmatic Drug Business (2019-2024)
11.16.5 Chengdu Huayu Pharmaceutical Co., Ltd Recent Development
11.17 Kaifeng Kangnuo Pharmaceutical Co., Ltd
11.17.1 Kaifeng Kangnuo Pharmaceutical Co., Ltd Company Detail
11.17.2 Kaifeng Kangnuo Pharmaceutical Co., Ltd Business Overview
11.17.3 Kaifeng Kangnuo Pharmaceutical Co., Ltd Antiasthmatic Drug Introduction
11.17.4 Kaifeng Kangnuo Pharmaceutical Co., Ltd Revenue in Antiasthmatic Drug Business (2019-2024)
11.17.5 Kaifeng Kangnuo Pharmaceutical Co., Ltd Recent Development
11.18 Akorn Pharmaceutical Co.Ltd.
11.18.1 Akorn Pharmaceutical Co.Ltd. Company Detail
11.18.2 Akorn Pharmaceutical Co.Ltd. Business Overview
11.18.3 Akorn Pharmaceutical Co.Ltd. Antiasthmatic Drug Introduction
11.18.4 Akorn Pharmaceutical Co.Ltd. Revenue in Antiasthmatic Drug Business (2019-2024)
11.18.5 Akorn Pharmaceutical Co.Ltd. Recent Development
11.19 Boehringer Ingelheim Pharma GmbH&Co.KG
11.19.1 Boehringer Ingelheim Pharma GmbH&Co.KG Company Detail
11.19.2 Boehringer Ingelheim Pharma GmbH&Co.KG Business Overview
11.19.3 Boehringer Ingelheim Pharma GmbH&Co.KG Antiasthmatic Drug Introduction
11.19.4 Boehringer Ingelheim Pharma GmbH&Co.KG Revenue in Antiasthmatic Drug Business (2019-2024)
11.19.5 Boehringer Ingelheim Pharma GmbH&Co.KG Recent Development
11.20 Covis Pharmaceutical Inc
11.20.1 Covis Pharmaceutical Inc Company Detail
11.20.2 Covis Pharmaceutical Inc Business Overview
11.20.3 Covis Pharmaceutical Inc Antiasthmatic Drug Introduction
11.20.4 Covis Pharmaceutical Inc Revenue in Antiasthmatic Drug Business (2019-2024)
11.20.5 Covis Pharmaceutical Inc Recent Development
11.21 Roche
11.21.1 Roche Company Detail
11.21.2 Roche Business Overview
11.21.3 Roche Antiasthmatic Drug Introduction
11.21.4 Roche Revenue in Antiasthmatic Drug Business (2019-2024)
11.21.5 Roche Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Antiasthmatic Drug Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Bronchodilators
Table 3. Key Players of Anti-allergic Antiasthmatic
Table 4. Key Players of Anti-inflammatory Antiasthmatic
Table 5. Global Antiasthmatic Drug Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Antiasthmatic Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Antiasthmatic Drug Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Antiasthmatic Drug Market Share by Region (2019-2024)
Table 9. Global Antiasthmatic Drug Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Antiasthmatic Drug Market Share by Region (2025-2030)
Table 11. Antiasthmatic Drug Market Trends
Table 12. Antiasthmatic Drug Market Drivers
Table 13. Antiasthmatic Drug Market Challenges
Table 14. Antiasthmatic Drug Market Restraints
Table 15. Global Antiasthmatic Drug Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Antiasthmatic Drug Market Share by Players (2019-2024)
Table 17. Global Top Antiasthmatic Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiasthmatic Drug as of 2023)
Table 18. Ranking of Global Top Antiasthmatic Drug Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Antiasthmatic Drug Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Antiasthmatic Drug Product Solution and Service
Table 22. Date of Enter into Antiasthmatic Drug Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Antiasthmatic Drug Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Antiasthmatic Drug Revenue Market Share by Type (2019-2024)
Table 26. Global Antiasthmatic Drug Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Antiasthmatic Drug Revenue Market Share by Type (2025-2030)
Table 28. Global Antiasthmatic Drug Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Antiasthmatic Drug Revenue Market Share by Application (2019-2024)
Table 30. Global Antiasthmatic Drug Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Antiasthmatic Drug Revenue Market Share by Application (2025-2030)
Table 32. North America Antiasthmatic Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Antiasthmatic Drug Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Antiasthmatic Drug Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Antiasthmatic Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Antiasthmatic Drug Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Antiasthmatic Drug Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Antiasthmatic Drug Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Antiasthmatic Drug Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Antiasthmatic Drug Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Antiasthmatic Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Antiasthmatic Drug Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Antiasthmatic Drug Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Antiasthmatic Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Antiasthmatic Drug Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Antiasthmatic Drug Market Size by Country (2025-2030) & (US$ Million)
Table 47. Novartis AG Company Detail
Table 48. Novartis AG Business Overview
Table 49. Novartis AG Antiasthmatic Drug Product
Table 50. Novartis AG Revenue in Antiasthmatic Drug Business (2019-2024) & (US$ Million)
Table 51. Novartis AG Recent Development
Table 52. GlaxoSmithKline Company Detail
Table 53. GlaxoSmithKline Business Overview
Table 54. GlaxoSmithKline Antiasthmatic Drug Product
Table 55. GlaxoSmithKline Revenue in Antiasthmatic Drug Business (2019-2024) & (US$ Million)
Table 56. GlaxoSmithKline Recent Development
Table 57. ABC Farmaceutici Spa Company Detail
Table 58. ABC Farmaceutici Spa Business Overview
Table 59. ABC Farmaceutici Spa Antiasthmatic Drug Product
Table 60. ABC Farmaceutici Spa Revenue in Antiasthmatic Drug Business (2019-2024) & (US$ Million)
Table 61. ABC Farmaceutici Spa Recent Development
Table 62. AstraZeneca Company Detail
Table 63. AstraZeneca Business Overview
Table 64. AstraZeneca Antiasthmatic Drug Product
Table 65. AstraZeneca Revenue in Antiasthmatic Drug Business (2019-2024) & (US$ Million)
Table 66. AstraZeneca Recent Development
Table 67. Teva Pharmaceutical Industries Ltd Company Detail
Table 68. Teva Pharmaceutical Industries Ltd Business Overview
Table 69. Teva Pharmaceutical Industries Ltd Antiasthmatic Drug Product
Table 70. Teva Pharmaceutical Industries Ltd Revenue in Antiasthmatic Drug Business (2019-2024) & (US$ Million)
Table 71. Teva Pharmaceutical Industries Ltd Recent Development
Table 72. Mundipharma Pharmaceuticals Ltd. Company Detail
Table 73. Mundipharma Pharmaceuticals Ltd. Business Overview
Table 74. Mundipharma Pharmaceuticals Ltd. Antiasthmatic Drug Product
Table 75. Mundipharma Pharmaceuticals Ltd. Revenue in Antiasthmatic Drug Business (2019-2024) & (US$ Million)
Table 76. Mundipharma Pharmaceuticals Ltd. Recent Development
Table 77. MSD Company Detail
Table 78. MSD Business Overview
Table 79. MSD Antiasthmatic Drug Product
Table 80. MSD Revenue in Antiasthmatic Drug Business (2019-2024) & (US$ Million)
Table 81. MSD Recent Development
Table 82. Daiichi Sankyo Company Limited Company Detail
Table 83. Daiichi Sankyo Company Limited Business Overview
Table 84. Daiichi Sankyo Company Limited Antiasthmatic Drug Product
Table 85. Daiichi Sankyo Company Limited Revenue in Antiasthmatic Drug Business (2019-2024) & (US$ Million)
Table 86. Daiichi Sankyo Company Limited Recent Development
Table 87. Chiesi GmbH Company Detail
Table 88. Chiesi GmbH Business Overview
Table 89. Chiesi GmbH Antiasthmatic Drug Product
Table 90. Chiesi GmbH Revenue in Antiasthmatic Drug Business (2019-2024) & (US$ Million)
Table 91. Chiesi GmbH Recent Development
Table 92. Kyorin Pharmaceutical Co.,Ltd. Company Detail
Table 93. Kyorin Pharmaceutical Co.,Ltd. Business Overview
Table 94. Kyorin Pharmaceutical Co.,Ltd. Antiasthmatic Drug Product
Table 95. Kyorin Pharmaceutical Co.,Ltd. Revenue in Antiasthmatic Drug Business (2019-2024) & (US$ Million)
Table 96. Kyorin Pharmaceutical Co.,Ltd. Recent Development
Table 97. Kissei Pharmaceutical Co.Ltd. Company Detail
Table 98. Kissei Pharmaceutical Co.Ltd. Business Overview
Table 99. Kissei Pharmaceutical Co.Ltd. Antiasthmatic Drug Product
Table 100. Kissei Pharmaceutical Co.Ltd. Revenue in Antiasthmatic Drug Business (2019-2024) & (US$ Million)
Table 101. Kissei Pharmaceutical Co.Ltd. Recent Development
Table 102. Ruiyang Pharmaceutical Co., Ltd Company Detail
Table 103. Ruiyang Pharmaceutical Co., Ltd Business Overview
Table 104. Ruiyang Pharmaceutical Co., Ltd Antiasthmatic Drug Product
Table 105. Ruiyang Pharmaceutical Co., Ltd Revenue in Antiasthmatic Drug Business (2019-2024) & (US$ Million)
Table 106. Ruiyang Pharmaceutical Co., Ltd Recent Development
Table 107. Chiesi Pharmaceutical (Shangai) Co., Ltd Company Detail
Table 108. Chiesi Pharmaceutical (Shangai) Co., Ltd Business Overview
Table 109. Chiesi Pharmaceutical (Shangai) Co., Ltd Antiasthmatic Drug Product
Table 110. Chiesi Pharmaceutical (Shangai) Co., Ltd Revenue in Antiasthmatic Drug Business (2019-2024) & (US$ Million)
Table 111. Chiesi Pharmaceutical (Shangai) Co., Ltd Recent Development
Table 112. Fuhe Group Company Detail
Table 113. Fuhe Group Business Overview
Table 114. Fuhe Group Antiasthmatic Drug Product
Table 115. Fuhe Group Revenue in Antiasthmatic Drug Business (2019-2024) & (US$ Million)
Table 116. Fuhe Group Recent Development
Table 117. Lunan Pharmaceutical Group Co., Ltd Company Detail
Table 118. Lunan Pharmaceutical Group Co., Ltd Business Overview
Table 119. Lunan Pharmaceutical Group Co., Ltd Antiasthmatic Drug Product
Table 120. Lunan Pharmaceutical Group Co., Ltd Revenue in Antiasthmatic Drug Business (2019-2024) & (US$ Million)
Table 121. Lunan Pharmaceutical Group Co., Ltd Recent Development
Table 122. Chengdu Huayu Pharmaceutical Co., Ltd Company Detail
Table 123. Chengdu Huayu Pharmaceutical Co., Ltd Business Overview
Table 124. Chengdu Huayu Pharmaceutical Co., Ltd Antiasthmatic Drug Product
Table 125. Chengdu Huayu Pharmaceutical Co., Ltd Revenue in Antiasthmatic Drug Business (2019-2024) & (US$ Million)
Table 126. Chengdu Huayu Pharmaceutical Co., Ltd Recent Development
Table 127. Kaifeng Kangnuo Pharmaceutical Co., Ltd Company Detail
Table 128. Kaifeng Kangnuo Pharmaceutical Co., Ltd Business Overview
Table 129. Kaifeng Kangnuo Pharmaceutical Co., Ltd Antiasthmatic Drug Product
Table 130. Kaifeng Kangnuo Pharmaceutical Co., Ltd Revenue in Antiasthmatic Drug Business (2019-2024) & (US$ Million)
Table 131. Kaifeng Kangnuo Pharmaceutical Co., Ltd Recent Development
Table 132. Akorn Pharmaceutical Co.Ltd. Company Detail
Table 133. Akorn Pharmaceutical Co.Ltd. Business Overview
Table 134. Akorn Pharmaceutical Co.Ltd. Antiasthmatic Drug Product
Table 135. Akorn Pharmaceutical Co.Ltd. Revenue in Antiasthmatic Drug Business (2019-2024) & (US$ Million)
Table 136. Akorn Pharmaceutical Co.Ltd. Recent Development
Table 137. Boehringer Ingelheim Pharma GmbH&Co.KG Company Detail
Table 138. Boehringer Ingelheim Pharma GmbH&Co.KG Business Overview
Table 139. Boehringer Ingelheim Pharma GmbH&Co.KG Antiasthmatic Drug Product
Table 140. Boehringer Ingelheim Pharma GmbH&Co.KG Revenue in Antiasthmatic Drug Business (2019-2024) & (US$ Million)
Table 141. Boehringer Ingelheim Pharma GmbH&Co.KG Recent Development
Table 142. Covis Pharmaceutical Inc Company Detail
Table 143. Covis Pharmaceutical Inc Business Overview
Table 144. Covis Pharmaceutical Inc Antiasthmatic Drug Product
Table 145. Covis Pharmaceutical Inc Revenue in Antiasthmatic Drug Business (2019-2024) & (US$ Million)
Table 146. Covis Pharmaceutical Inc Recent Development
Table 147. Roche Company Detail
Table 148. Roche Business Overview
Table 149. Roche Antiasthmatic Drug Product
Table 150. Roche Revenue in Antiasthmatic Drug Business (2019-2024) & (US$ Million)
Table 151. Roche Recent Development
Table 152. Research Programs/Design for This Report
Table 153. Key Data Information from Secondary Sources
Table 154. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Antiasthmatic Drug Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Antiasthmatic Drug Market Share by Type: 2023 VS 2030
Figure 3. Bronchodilators Features
Figure 4. Anti-allergic Antiasthmatic Features
Figure 5. Anti-inflammatory Antiasthmatic Features
Figure 6. Global Antiasthmatic Drug Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Antiasthmatic Drug Market Share by Application: 2023 VS 2030
Figure 8. Need for Acute Attack of Asthma Case Studies
Figure 9. Treatment of Chronic Asthma Case Studies
Figure 10. Antiasthmatic Drug Report Years Considered
Figure 11. Global Antiasthmatic Drug Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Antiasthmatic Drug Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Antiasthmatic Drug Market Share by Region: 2023 VS 2030
Figure 14. Global Antiasthmatic Drug Market Share by Players in 2023
Figure 15. Global Top Antiasthmatic Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiasthmatic Drug as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Antiasthmatic Drug Revenue in 2023
Figure 17. North America Antiasthmatic Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Antiasthmatic Drug Market Share by Country (2019-2030)
Figure 19. United States Antiasthmatic Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Antiasthmatic Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Antiasthmatic Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Antiasthmatic Drug Market Share by Country (2019-2030)
Figure 23. Germany Antiasthmatic Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Antiasthmatic Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Antiasthmatic Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Antiasthmatic Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Antiasthmatic Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Antiasthmatic Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Antiasthmatic Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Antiasthmatic Drug Market Share by Region (2019-2030)
Figure 31. China Antiasthmatic Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Antiasthmatic Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Antiasthmatic Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Antiasthmatic Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Antiasthmatic Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Antiasthmatic Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Antiasthmatic Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Antiasthmatic Drug Market Share by Country (2019-2030)
Figure 39. Mexico Antiasthmatic Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Antiasthmatic Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Antiasthmatic Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Antiasthmatic Drug Market Share by Country (2019-2030)
Figure 43. Turkey Antiasthmatic Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Antiasthmatic Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Novartis AG Revenue Growth Rate in Antiasthmatic Drug Business (2019-2024)
Figure 46. GlaxoSmithKline Revenue Growth Rate in Antiasthmatic Drug Business (2019-2024)
Figure 47. ABC Farmaceutici Spa Revenue Growth Rate in Antiasthmatic Drug Business (2019-2024)
Figure 48. AstraZeneca Revenue Growth Rate in Antiasthmatic Drug Business (2019-2024)
Figure 49. Teva Pharmaceutical Industries Ltd Revenue Growth Rate in Antiasthmatic Drug Business (2019-2024)
Figure 50. Mundipharma Pharmaceuticals Ltd. Revenue Growth Rate in Antiasthmatic Drug Business (2019-2024)
Figure 51. MSD Revenue Growth Rate in Antiasthmatic Drug Business (2019-2024)
Figure 52. Daiichi Sankyo Company Limited Revenue Growth Rate in Antiasthmatic Drug Business (2019-2024)
Figure 53. Chiesi GmbH Revenue Growth Rate in Antiasthmatic Drug Business (2019-2024)
Figure 54. Kyorin Pharmaceutical Co.,Ltd. Revenue Growth Rate in Antiasthmatic Drug Business (2019-2024)
Figure 55. Kissei Pharmaceutical Co.Ltd. Revenue Growth Rate in Antiasthmatic Drug Business (2019-2024)
Figure 56. Ruiyang Pharmaceutical Co., Ltd Revenue Growth Rate in Antiasthmatic Drug Business (2019-2024)
Figure 57. Chiesi Pharmaceutical (Shangai) Co., Ltd Revenue Growth Rate in Antiasthmatic Drug Business (2019-2024)
Figure 58. Fuhe Group Revenue Growth Rate in Antiasthmatic Drug Business (2019-2024)
Figure 59. Lunan Pharmaceutical Group Co., Ltd Revenue Growth Rate in Antiasthmatic Drug Business (2019-2024)
Figure 60. Chengdu Huayu Pharmaceutical Co., Ltd Revenue Growth Rate in Antiasthmatic Drug Business (2019-2024)
Figure 61. Kaifeng Kangnuo Pharmaceutical Co., Ltd Revenue Growth Rate in Antiasthmatic Drug Business (2019-2024)
Figure 62. Akorn Pharmaceutical Co.Ltd. Revenue Growth Rate in Antiasthmatic Drug Business (2019-2024)
Figure 63. Boehringer Ingelheim Pharma GmbH&Co.KG Revenue Growth Rate in Antiasthmatic Drug Business (2019-2024)
Figure 64. Covis Pharmaceutical Inc Revenue Growth Rate in Antiasthmatic Drug Business (2019-2024)
Figure 65. Roche Revenue Growth Rate in Antiasthmatic Drug Business (2019-2024)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
